fingolimod hydrochloride has been researched along with Granulocytic Leukemia, Chronic in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cao, P; Chai, S; Liu, J; Sun, S; Wang, Y; Wu, K; Xiao, X; Yan, H; Yang, C; Yuan, Y; Zhang, J; Zhao, M | 1 |
| Chinen, Y; Horiike, S; Kiyota, M; Kobayashi, T; Kuroda, J; Matsumoto, Y; Mizutani, S; Nagoshi, H; Nakayama, R; Sakamoto, N; Sasaki, N; Shimura, Y; Taniwaki, M; Yamamoto-Sugitani, M | 1 |
| Apperley, J; Arlinghaus, RB; Bhatia, R; Bielawski, J; Bittman, R; Blum, W; Byrd, JC; Caligiuri, MA; Chen, CS; Cortes, J; Croce, CM; Devine, S; Dorrance, AM; Eiring, AM; Ellis, JJ; Ferenchak, G; Garzon, R; Goldman, JM; Harb, JG; Hokland, P; Holyoake, TL; Huettner, CS; Klisovic, RB; Koschmieder, S; Ma, Y; Mao, HC; Marcucci, G; May, PC; Milojkovic, D; Mulloy, JC; Neviani, P; Oaks, JJ; Ogretmen, B; Paisie, CA; Perrotti, D; Reid, A; Roy, DC; Saddoughi, SA; Santhanam, R; Solt, JA; Sun, C; Volinia, S; Walker, CJ; Wunderlich, M; Zhang, B | 1 |
| Blaser, BW; Bloomfield, CD; Byrd, JC; Caligiuri, MA; Chen, CS; Cortes, J; Druker, BJ; Eiring, AM; Gambacorti-Passerini, C; Liu, S; Marcucci, G; Muthusamy, N; Neviani, P; Notari, M; Oaks, JJ; Perrotti, D; Roy, DC; Santhanam, R; Trotta, R; Verrills, NM | 1 |
4 other study(ies) available for fingolimod hydrochloride and Granulocytic Leukemia, Chronic
| Article | Year |
|---|---|
Curcumol and FTY720 synergistically induce apoptosis and differentiation in chronic myelomonocytic leukemia via multiple signaling pathways.
Topics: Animals; Apoptosis; Cell Differentiation; Cell Proliferation; Disease Models, Animal; Fingolimod Hydrochloride; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Mice; Sesquiterpenes; Signal Transduction | 2021 |
FTY720 induces apoptosis of chronic myelogenous leukemia cells via dual activation of BIM and BID and overcomes various types of resistance to tyrosine kinase inhibitors.
Topics: Antineoplastic Agents; Apoptosis; Apoptosis Regulatory Proteins; Bcl-2-Like Protein 11; bcl-Associated Death Protein; BH3 Interacting Domain Death Agonist Protein; Cell Line, Tumor; Drug Resistance, Neoplasm; Fas-Associated Death Domain Protein; Fingolimod Hydrochloride; Gene Expression Regulation, Leukemic; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Membrane Proteins; Mutation; Primary Cell Culture; Propylene Glycols; Protein Kinase Inhibitors; Proto-Oncogene Proteins; RNA, Small Interfering; Signal Transduction; Sphingosine | 2013 |
PP2A-activating drugs selectively eradicate TKI-resistant chronic myeloid leukemic stem cells.
Topics: Animals; Antineoplastic Agents; Apoptosis; beta Catenin; Cell Proliferation; Cell Survival; Drug Resistance, Neoplasm; Enzyme Activators; Fingolimod Hydrochloride; Fusion Proteins, bcr-abl; Hematopoietic Stem Cells; Humans; Janus Kinase 2; K562 Cells; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Mice; Mice, Transgenic; Neoplastic Stem Cells; Propylene Glycols; Protein Kinase Inhibitors; Protein Phosphatase 2; Sphingosine; Wnt Signaling Pathway; Xenograft Model Antitumor Assays | 2013 |
FTY720, a new alternative for treating blast crisis chronic myelogenous leukemia and Philadelphia chromosome-positive acute lymphocytic leukemia.
Topics: Animals; Benzamides; Blast Crisis; Cell Survival; Dasatinib; Drug Resistance, Neoplasm; Fingolimod Hydrochloride; Fusion Proteins, bcr-abl; Gene Expression Regulation, Neoplastic; Humans; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Mice; Molecular Structure; Phosphoprotein Phosphatases; Phosphorylation; Piperazines; Propylene Glycols; Protein Phosphatase 2; Pyrimidines; Signal Transduction; Sphingosine; Thiazoles; Time Factors; Tumor Cells, Cultured | 2007 |